Cancer - Confidence will be on the rise. You will advance important tasks with preparation and courage. You will be comfortable in social interactions. Brotherhood will be encouraged. Bonds will be ...

When cell division (mitosis) takes too long, it can be a sign that something is wrong with the cells, for example, DNA damage or chromosomal instability. That's why our cells come with an innate ...

Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites seeding new resistant tumors elsewhere in the body. Combating the problem has ...

A Northwestern Medicine study published in the Journal of Clinical Investigation has uncovered a connection between a well-known cancer-related protein and a major RNA modification process, which may ...

The pipeline of investigational therapies for hereditary angioedema (HAE) includes both novel inhibitors of known molecular targets and more ambitious gene editing-based approaches. Selected agents ...

High CD8-positive T cell infiltration is linked to shorter PFS in epithelial ovarian cancer patients treated with bevacizumab. The IMM subtype, which usually has a favorable prognosis, showed worse ...

Researchers have designed a smart drug that hunts down and breaks a little-known RNA that cancer cells depend on. The drug recognizes a unique fold in the RNA and triggers the cell to destroy it.

Eli Lilly has penned a research pact worth $1.2 billion in biobucks with SanegeneBio to help pinpoint cardiometabolic RNAi medicines at the correct tissues. The agreement centers around Sanegene’s ...

This review proposes to achieve the targeted development and fabrication of high-performance high-temperature electromagnetic shielding ceramics through microstructural engineering, additive ...

The researchers used lipid nanoparticles (LNPs) to deliver cyclic GMP-AMP (cGAMP) synthase (cGAS) mRNA to cancer cells. This results in production of the endogenous stimulator of interferon genes ...

Novartis has made RNA medicines one of its top strategic goals and it already has RNA therapies for cardiovascular indications. The pharmaceutical giant is now placing one of its biggest ever bets ...